Amelie Elsäßer

562 total citations
17 papers, 382 citations indexed

About

Amelie Elsäßer is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Molecular Biology. According to data from OpenAlex, Amelie Elsäßer has authored 17 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Amelie Elsäßer's work include Cardiac Imaging and Diagnostics (4 papers), Advanced MRI Techniques and Applications (4 papers) and Statistical Methods in Clinical Trials (4 papers). Amelie Elsäßer is often cited by papers focused on Cardiac Imaging and Diagnostics (4 papers), Advanced MRI Techniques and Applications (4 papers) and Statistical Methods in Clinical Trials (4 papers). Amelie Elsäßer collaborates with scholars based in Germany, United States and Switzerland. Amelie Elsäßer's co-authors include Anja Victor, Tianxi Cai, Victoria Gamerman, Maria Blettner, Gerhard Hommel, Franz Koenig, Thorsten Vetter, Martin Posch, Jan Regnström and Marisa Papaluca‐Amati and has published in prestigious journals such as Diabetes Care, The American Journal of Cardiology and Annals of Oncology.

In The Last Decade

Amelie Elsäßer

16 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amelie Elsäßer Germany 11 65 61 61 56 52 17 382
William L. Greene United States 12 74 1.1× 24 0.4× 46 0.8× 30 0.5× 45 0.9× 34 633
Bradley Patay United States 4 69 1.1× 34 0.6× 52 0.9× 19 0.3× 60 1.2× 10 492
Nathalie C. Støer Norway 14 62 1.0× 44 0.7× 46 0.8× 152 2.7× 13 0.3× 48 597
Phyllis Chan United States 15 54 0.8× 39 0.6× 40 0.7× 161 2.9× 14 0.3× 38 567
Karoline Kuchenbaecker United Kingdom 12 234 3.6× 119 2.0× 19 0.3× 74 1.3× 23 0.4× 28 962
Eugene C. Grochowski United States 4 23 0.4× 31 0.5× 40 0.7× 34 0.6× 94 1.8× 8 642
Elizabeth J. Conroy United Kingdom 14 141 2.2× 34 0.6× 17 0.3× 19 0.3× 67 1.3× 37 680
Louise A C Millard United Kingdom 16 155 2.4× 14 0.2× 29 0.5× 17 0.3× 9 0.2× 31 690
Alexei Ionan United States 8 204 3.1× 35 0.6× 24 0.4× 89 1.6× 10 0.2× 11 519

Countries citing papers authored by Amelie Elsäßer

Since Specialization
Citations

This map shows the geographic impact of Amelie Elsäßer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelie Elsäßer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelie Elsäßer more than expected).

Fields of papers citing papers by Amelie Elsäßer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amelie Elsäßer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelie Elsäßer. The network helps show where Amelie Elsäßer may publish in the future.

Co-authorship network of co-authors of Amelie Elsäßer

This figure shows the co-authorship network connecting the top 25 collaborators of Amelie Elsäßer. A scholar is included among the top collaborators of Amelie Elsäßer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amelie Elsäßer. Amelie Elsäßer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tuttle, Katherine R., Adeera Levin, Masaomi Nangaku, et al.. (2022). Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials. Diabetes Care. 45(6). 1445–1452. 30 indexed citations
2.
Tuttle, Katherine R., Adeera Levin, Masaomi Nangaku, et al.. (2022). Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials. Figshare. 2 indexed citations
3.
Gamerman, Victoria, Tianxi Cai, & Amelie Elsäßer. (2018). Pragmatic randomized clinical trials: best practices and statistical guidance. Health Services and Outcomes Research Methodology. 19(1). 23–35. 62 indexed citations
4.
Abegunewardene, Nico, Karl‐Friedrich Kreitner, Katja Oberholzer, et al.. (2016). Serial assessments of microvascular obstruction by contrast-enhanced magnetic resonance predict contractile recovery and clinical outcome after reperfused acute myocardial infarction. Clinical Hemorheology and Microcirculation. 62(4). 345–357. 3 indexed citations
5.
Simon, Petra, Andrea Breitkreuz, Ulrich Luxemburger, et al.. (2015). Humoral immune responses of lung cancer patients against the Transmembrane Phosphatase with TEnsin homology (TPTE). Lung Cancer. 90(2). 334–341. 17 indexed citations
6.
Brochhausen, Christoph, Volker H. Schmitt, David Hollemann, et al.. (2015). LATE-BREAKING ABSTRACT: Comparative studies on bronchuswall-thickness by histologic and computed tomographic measurements of porcine lungs. PA3737–PA3737.
7.
Elsäßer, Amelie, Jan Regnström, Thorsten Vetter, et al.. (2014). Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency. Trials. 15(1). 383–383. 55 indexed citations
8.
Schmidtmann, Irene, Amelie Elsäßer, Arndt Weinmann, & Harald Binder. (2014). Coupled variable selection for regression modeling of complex treatment patterns in a clinical cancer registry. Statistics in Medicine. 33(30). 5358–5370. 5 indexed citations
9.
Voigtländer, Thomas, Axel Schmermund, Peter Bramlage, et al.. (2011). The Adverse Events and Hemodynamic Effects of Adenosine-Based Cardiac MRI. Korean Journal of Radiology. 12(4). 433–433. 1 indexed citations
10.
Voigtländer, Thomas, Axel Schmermund, Peter Bramlage, et al.. (2011). The Adverse Events and Hemodynamic Effects of Adenosine-Based Cardiac MRI. Korean Journal of Radiology. 12(4). 424–424. 11 indexed citations
12.
Victor, Anja, Amelie Elsäßer, Gerhard Hommel, & Maria Blettner. (2010). Judging a Plethora of p-Values. Deutsches Ärzteblatt international. 107(4). 50–6. 76 indexed citations
13.
Tadić, André, Amelie Elsäßer, Niels Storm, et al.. (2010). Association analysis between gene variants of the tyrosine hydroxylase and the serotonin transporter in borderline personality disorder. The World Journal of Biological Psychiatry. 11(1). 45–58. 12 indexed citations
14.
Tadić, André, Amelie Elsäßer, Anja Victor, et al.. (2009). Association analysis of serotonin receptor 1B (HTR1B) and brain-derived neurotrophic factor gene polymorphisms in borderline personality disorder. Journal of Neural Transmission. 116(9). 1185–1188. 15 indexed citations
15.
Roos, Frederik C., Anja Victor, Amelie Elsäßer, et al.. (2009). Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma. British Journal of Urology. 104(4). 461–469. 13 indexed citations
16.
Roos, Frederik C., Sascha Pahernik, Amelie Elsäßer, et al.. (2008). Imperative organerhaltende Nierentumorchirugie bei Einzelniere bzw. bilateralen Tumoren. Der Urologe. 47(7). 818–823. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026